Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

Stopped Phase II was not pursued due to futility based on the results of the NAPOLI-3 therapeutic clinical trial.

Conditions

• Pancreatic Cancer

Interventions

• DRUG: Gemcitabine
• DRUG: Nab-paclitaxel
• DRUG: Paricalcitol
• OTHER: Placebo

Sponsor

Dana-Farber Cancer Institute

Collaborators

• [object Object]
• [object Object]
• [object Object]